Literature DB >> 2149993

Malignant cells of epithelial phenotype limited to thoracic lymph nodes.

V E Gould1, W H Warren, L P Faber, C Kuhn, W W Franke.   

Abstract

Asymptomatic thoracic lymphadenopathy was incidentally discovered in three patients with no definitive diagnoses. Enlarged lymph nodes, removed at thoracotomy, had irregularly distributed, pleomorphic, malignant-appearing cells. Mitoses were frequent. Electron microscopy showed tonofilament bundles and desmosomes. By immunocytochemistry, these cells uniformly expressed desmoplakin and cytokeratins 8 and 18 and various patterns of coexpression with other cytokeratins. One patient had lymphadenectomy, segmental lung resection and radiotherapy; the second had lymphadenectomy and later a lymphadenectomy with pneumonectomy; and the third had lymphadenectomy and radiotherapy. Neoplastic cells were detected exclusively within thoracic lymph nodes. The patients are well 111, 39 and 13 months after initial presentation. The clinical course and the patterns of intranodal distribution and marker expression of the neoplastic cells are unusual and distinct from most carcinomas metastatic to lymph nodes and reminiscent of "lymphoepithelioma-like carcinomas" described in the thymus and other sites. While the malignant cells may reflect metastases from as yet occult primaries or malignantly transformed ectopic epithelial nests, these tumours may arise by transformation from the cytokeratin-positive "extrafollicular reticulum cells" indigenous to lymphoid organs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149993     DOI: 10.1016/0277-5379(90)90267-w

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Fibroblastic reticular cell tumor of the breast: A case report and review of the literature.

Authors:  Hongmei Li; Pingrong Shen; Yun Liang; Feng Zhang
Journal:  Exp Ther Med       Date:  2015-12-08       Impact factor: 2.447

2.  Outcomes of Stage III NSCLC with occult primary vs. known primary lesions.

Authors:  Paul B Romesser; Yonatan Bardash; Darren Buonocore; Jamie E Chaft; James Huang; David R Jones; Andreas Rimner; Abraham J Wu
Journal:  Lung Cancer       Date:  2018-11-17       Impact factor: 5.705

3.  Increased numbers of cytokeratin-positive interstitial reticulum cells (CIRC) in reactive, inflammatory and neoplastic lymphadenopathies: hyperplasia or induced expression?

Authors:  V E Gould; K J Bloom; W W Franke; W H Warren; R Moll
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  A Rare Case of Cytokeratin-Positive Interstitial Reticulum Cell Sarcoma and Review of the Entity.

Authors:  Shravasti Roy; Indranil Das; Kaushik Saha; Rakesh Roy; Sumanta Bhattacharya
Journal:  Indian J Surg Oncol       Date:  2015-03-11

5.  An Overt, Obscure Gastrointestinal Bleed Caused by a Primary Small Bowel Fibroblastic Reticular Cell Sarcoma.

Authors:  Stephanie L Gold; Shirley Cohen-Mekelburg; Russell Rosenblatt; Jose Jessurun; Reem Sharaiha; Karim Halazun; David Wan
Journal:  ACG Case Rep J       Date:  2018-03-14

6.  Lymph node cancer of the mediastinum with a putative necrotic primary lesion in the lung: a case report.

Authors:  Daichi Shikata; Takahiro Nakagomi; Rumi Higuchi; Yujiro Yokoyama; Toshio Oyama; Taichiro Goto
Journal:  World J Surg Oncol       Date:  2018-04-02       Impact factor: 2.754

7.  Cytokeratin-positive interstitial reticulum cell (CIRC) tumor in the lymph node: a case report of the transformation from the epithelioid cell type to the spindle cell type.

Authors:  Sachiko Kaji; Nobuyuki Hiruta; Daisuke Sasai; Makoto Nagashima; Rintaro Ohe; Mitsunori Yamakawa
Journal:  Diagn Pathol       Date:  2020-09-26       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.